Vimarsana
Biggest News Aggregation in the World

Page 10 - Robert Barrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Barrow Today - Breaking & Trending Today

Mind Medicine (MindMed) (MNMD) Set to Announce Quarterly Earnings on Wednesday - Vimarsana News

Mind Medicine (MindMed) (MNMD) Set to Announce Quarterly Earnings on Wednesday

Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, February 28th. Analysts expect Mind Medicine (MindMed) to post earnings of ($0.48) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so […]

Brokerages Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $23.50 - Vimarsana News

Brokerages Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $23.50

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have updated their coverage on […]

Legendary lensman – Winnipeg Free Press - Vimarsana News

Legendary lensman – Winnipeg Free Press

Breaking News, Sports, Manitoba, Canada

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by Brokerages - Vimarsana News

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by Brokerages

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on […]

FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000 - Johnson & Johnson (NYSE:JNJ), Mind Medicine (NASDAQ:MNMD) - Vimarsana News

FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000 - Johnson & Johnson (NYSE:JNJ), Mind Medicine (NASDAQ:MNMD)

FDA and Reagan-Udall Foundation are hosting a virtual public meeting on psychedelic research titled Advancing Psychedelic Clinical Study Design, which aims to explore empirical approaches to address issues in drug development.